Division News

Amy Abernethy, MD, associate professor medicine (Medical Oncology) and director of the Duke Cancer Care Research Program and Center for Learning Health Care, was named one of the 30 most influential leaders in hospice and palliative medicine by the Amer

Mary Klotman, MD, chair of the Department of Medicine, and Michael Kastan, MD, PhD, executive director of the Duke Cancer Institute, announced today that James Abbruzzese, MD, has agreed to be the Chief of the Division of Medical Oncology and Associate Di

Jeffrey Peppercorn, MD, MPH, associate professor of medicine (Medical Oncology) has been named founding director of the Duke Cancer Institute's newly relaunched Duke Cancer Survivorship Center.

[caption id="attachment_12898" align="alignright" width="210"] Krish Patel, MD[/caption] Since he became the chief resident of Internal Medicine for Duke University Hospital, Krish Patel, MD, has learned first-hand the many logistical details in the Internal Medicine Residency Program. “There’s a part of my role that ends up being schedu

Susan G. Komen announced $3.6 million in research funding would go to 10 programs at Duke University and UNC-Chapel Hill.

Medicine Grand Rounds on Fri., June 21 at 8 a.m. in Duke Hospital room 2002 will feature Jeffrey M. Clarke, MD, chief resident of Internal Medicine at Duke University Medical Center. Dr. Clarke will present Novel Approaches Targeting Tumor Angiogenesis: Recent Advances and Future Strategies. Please note that Grand Rounds will not be recorded or live streamed this week.

Elizabeth Bigger, MD, fellow in Hematology-Oncology, shares her Documenting Medicine project "Financial Toxicity as a Consequence of Cancer Care." [vimeo 67759307 w=400 h=300]   Cancer treatment is incredibly expensive, and places a tremendous burden on patients – even those with insurance. The majority of bankruptcies in the United States are due to unpaid medical bills, and the rate of medical bankruptcies rapidly rises each year.

Thomas W. LeBlanc, MD, MA, fellow in both hospice and palliative medicine and medical oncology, and Yousuf Zafar, MD, MHS, assistant professor of medicine (Medical Oncology) were among the large contingent of Duke oncology faculty who attended the American Society of Clinical Oncology annual conference in Chicago last week. LeBlanc and Zafar both are active users of Twitter.

Please mark your calendars for a presentation by James L. Abbruzzese, MD, FACP, FASCO, DSc (hon.), professor of medicine and Waun Ki Hong Distinguished Char in Translational Oncology, Department of Gastrointestinal Oncology at The University of Texas M.D. Anderson Cancer Center, on Thurs., May 23 at 5:30 p.m. in 103 Bryan Research Building. Dr. Abbruzzese will present "Pancreatic Cancer: Recent Progress and a Look Forward."

Amy Abernethy, MD, associate professor of medicine (Medical Oncology) and director of both the Center for Learning Health Care and the Duke Cancer Care Research Program, spoke at TEDMED in April 2013. She presented Can patient data have a second life? Her talk starts around 1:30:00